Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.

MLA

Montay-Gruel, Pierre, et al. “Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma That Reduces Neurocognitive Side Effects in Mice.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367465866&authtype=sso&custid=ns315887.

APA

Montay-Gruel, P., Montay-Gruel, P., Acharya, M. M., Gonçalves Jorge, P., Petit, B., Petridis, I. G., Fuchs, P., Leavitt, R., Petersson, K., Gondré, M., Ollivier, J., Moeckli, R., Bochud, F., Bailat, C., Bourhis, J., Germond, J.-F., Limoli, C. L., & Vozenin, M.-C. (2021). Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research.

Chicago

Montay-Gruel, Pierre, Pierre Montay-Gruel, Munjal M Acharya, Patrik Gonçalves Jorge, Benoît Petit, Ioannis G Petridis, Philippe Fuchs, et al. 2021. “Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma That Reduces Neurocognitive Side Effects in Mice.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367465866&authtype=sso&custid=ns315887.